Search by Drug Name or NDC
NDC 68047-0752-01 ALLZITAL 325; 25 mg/1; mg/1 Details
ALLZITAL 325; 25 mg/1; mg/1
ALLZITAL is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Larken Laboratories, Inc.. The primary component is ACETAMINOPHEN; BUTALBITAL.
Product Information
| NDC | 68047-0752 |
|---|---|
| Product ID | 68047-752_0771bcff-6b38-c003-e063-6294a90a32a8 |
| Associated GPIs | 64991002120304 |
| GCN Sequence Number | 075526 |
| GCN Sequence Number Description | butalbital/acetaminophen TABLET 25MG-325MG ORAL |
| HIC3 | H3K |
| HIC3 Description | ANALGESIC, NON-SALICYLATE AND BARBITURATE COMBINAT |
| GCN | 40627 |
| HICL Sequence Number | 001858 |
| HICL Sequence Number Description | BUTALBITAL/ACETAMINOPHEN |
| Brand/Generic | Brand |
| Proprietary Name | ALLZITAL |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | butalbital and acetaminophen |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 325; 25 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; BUTALBITAL |
| Labeler Name | Larken Laboratories, Inc. |
| Pharmaceutical Class | Barbiturate [EPC], Barbiturates [CS] |
| DEA Schedule | CIII |
| Marketing Category | ANDA |
| Application Number | ANDA203484 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68047-0752-01 (68047075201)
| NDC Package Code | 68047-752-01 |
|---|---|
| Billing NDC | 68047075201 |
| Package | 100 TABLET in 1 BOTTLE (68047-752-01) |
| Marketing Start Date | 2015-12-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |